Abstract
The article presents the results of the open comparative randomized clinical study performed in children aged 3 to 17 years which were immunized with the Russian vaccine «EnceVir»® possessing the reduced antigenic load accordingly to emergency vaccination protocol. The aim of the study was to assess reactogenicity, safety and immunogenicity of the vaccine. The vaccine is characterized by a low reactogenicity profile, the high profile of safety, adequate immunogenicity, and it is not yielding to foreign vaccine «FSME-Immun Inject / Junior»
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
